HOME >> MEDICINE >> NEWS
New colorectal cancer screening recommendations for African Americans

Bethesda, MD, March 21, 2005 Physician experts from the American College of Gastroenterology have issued new recommendations to healthcare providers to begin colorectal cancer screening in African Americans at age 45 rather than 50 years. Colonoscopy is the preferred method of screening for colorectal cancer and data support the recommendation that African-Americans begin screening at a younger age because of the high incidence of colorectal cancer and a greater prevalence of proximal or right-sided polyps and cancerous lesions in this population.

The recommendations are published in the March issue of the American Journal of Gastroenterology. Overall, colorectal cancer is the second leading cause of cancer deaths in the United States. African Americans are diagnosed with colorectal cancer at a younger age than whites, and African Americans with colorectal cancer have decreased survival compared with whites. The article reviews the evidence why African Americans should have their colons screened for cancer at age 45 instead of age 50, five years earlier than the current recommendations. The article was drafted by the American College of Gastroenterology's Committee on Minority Affairs and Cultural Diversity.

The Committee recommends colonoscopy as a "first line" screening procedure for colorectal cancer for African Americans rather than flexible sigmoidoscopy because of the high overall risk and as well as some evidence that African Americans have more right-sided cancers and polyps. The right side of the colon includes the cecum, ascending colon and proximal transverse colon and cannot be reached by flexible sigmoidoscopy.

Clinical gastroenterologists play an important role in promoting colorectal cancer awareness and the need for screening in African Americans. Evidence suggests African Americans are more responsive to screening recommendations from their personal physicians than from other sources. The College urges physicians to
'"/>

Contact: Anne-Louise Oliphant
aloliphant@acg.gi.org
301-263-9000
American College of Gastroenterology
21-Mar-2005


Page: 1 2 3

Related medicine news :

1. Studies examine coffee drinking and risk of liver and colorectal cancers
2. Colonoscopy still most effective colorectal cancer screening method
3. More than 41 million Americans need colorectal cancer screening
4. Virtual colonoscopy shows significant promise as colorectal cancer screening option
5. Obese women face higher risk of colorectal cancer
6. New study of African-American and Hispanic colorectal cancer patients
7. Model predicting colorectal cancer screening suggests higher mortality for virtual colonoscopy
8. Doctors can improve colorectal cancer screening rates
9. Direct mailing of blood test kits increases colorectal cancer screening
10. Different methods of adjuvant chemotherapy for colorectal cancer have similar outcomes
11. NCI grant supports Jefferson trial to study test for colorectal cancer recurrence

Post Your Comments:
(Date:5/23/2013)... important human pathogen that can cause rapidly progressing, life ... said., "Until now we have not known how it ... long-standing mystery how it attaches to the airway to ... not get any symptoms, while some people progress to ... know the detail of how the bacterium colonises the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
(Date:5/23/2013)... DRE, Inc. is now offering the ... solution to upgrade older model DRE or BFW halogen ... system. , DRE and BFW customers can easily ... halogen headlights to LED with DRE’s American-made Xavier-C3 LED ... Kit provides a bright, clean and even field of ...
(Date:5/23/2013)... 2013 In Florida, residents have not been ... mean, however, that Florida’s good luck will continue, warns Rick ... year, he encourages residents, it is important to prepare as ... are predicting there to be a 50-percent chance that a ... hurricane season lasting from June 1 to November 30 in ...
(Date:5/23/2013)... Natchitoches, LA (PRWEB) May 23, 2013 The ... website, has showed that Louisiana still tops the rest of ... annual average of $2,699 is more than double of that ... factors determine auto insurance rates, and those factors vary from ... that may be causing these high rates. , Compared ...
Breaking Medicine News(10 mins):Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:Cunningham Financial Group Wants Motorists to Understand Their Rates as Louisiana’s Auto Insurance Rates Remain the Highest in the Nation 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: